Jones Financial Companies’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
59,906
+28,037
+88% +$638K ﹤0.01% 1699
2026
Q1
$653K Buy
31,869
+31,347
+6,005% +$652K ﹤0.01% 1914
2025
Q4
$11.2K Buy
522
+462
+770% +$9.47K ﹤0.01% 3171
2025
Q3
$978 Buy
60
+32
+114% +$480 ﹤0.01% 3902
2025
Q2
$393 Buy
+28
New +$384 ﹤0.01% 3840
2025
Q1
– Sell
-49
Closed -$643 – 3800
2024
Q4
$643 Buy
+49
New +$676 ﹤0.01% 3204
2013
Q3
– Sell
-566
Closed -$26K – 795
2013
Q2
$26K Buy
+566
New +$25.3K ﹤0.01% 418

Other funds holding MD

Jones Financial Companies's MD Position: Q2 2026 in Review

Jones Financial Companies increased its Pediatrix Medical (MD) stake by 88% in Q2 2026, buying an estimated $638K and bringing the position to 59,906 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

Jones Financial Companies first reported a position in MD in Q2 2013 and has held it in 7 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Jones Financial Companies held 59,906 shares of Pediatrix Medical worth $1.48M as of Q2 2026.
  • Jones Financial Companies bought 28,037 Pediatrix Medical shares in Q2 2026, an estimated $638K.
  • Pediatrix Medical made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1699 holding.
  • Jones Financial Companies first reported a position in Pediatrix Medical in Q2 2013 and has held it in 7 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.